Antimicrobial Peptide JH-3 Effectively Kills Salmonella enterica Serovar Typhimurium Strain CVCC541 and Reduces Its Pathogenicity in Mice
- 18 April 2019
- journal article
- research article
- Published by Springer Nature in Probiotics and Antimicrobial Proteins
- Vol. 11 (4) , 1379-1390
Abstract
Salmonella is an important zoonotic pathogen and is a major cause of gastrointestinal diseases worldwide. The current serious problem of antibiotic abuse has prompted the search for new substitutes for antibiotics. JH-3 is a small antimicrobial peptide with broad-spectrum bactericidal activity. In this study, we showed that JH-3 has good bactericidal activity towards the clinical isolate Salmonella enterica serovar Typhimurium strain CVCC541. The minimum inhibitory concentration (MIC) of JH-3 against this bacterium was determined to be 100 μg/mL, which could decrease the number of CVCC541 cells by 1000-fold in vitro within 5 h. The transmission electron microscopy (TEM) results showed that JH-3 can damage the cell wall and membrane of CVCC541, leading to the leakage of cell contents and subsequent cell death. To measure the bactericidal activity of CVCC541-infected mice were treated intraperitoneally 40 or 10 mg/kg JH-3 at 2 h or 3 days postinfection. Our results showed that treatment with 40 mg/kg JH-3 at 2 h postinfection had the best therapeutic effect and could significantly protect mice from a lethal dose of CVCC541. Furthermore, the clinical symptoms, bacterial burden in blood and organs, and intestinal pathological changes were all decreased and were close to normal. This study examined the therapeutic effect of the antimicrobial peptide JH-3 against S. enterica CVCC541 infection for the first time and determined the therapeutic effect of different JH-3 doses and treatment times, laying the foundation for studies of new antimicrobial agents.Keywords
Funding Information
- National Natural Science Foundation of China (31672559, 31702259)
- National Key Research and Development Program of China (2016YFD0500708-04)
- Program for Science Technology Innovation Talents in Universities of Henan Province (14HASTIT026)
- Financially supported by Excellent Youth Foundation of Henan Scientific Committee (174100510005)
This publication has 37 references indexed in Scilit:
- The Equine Antimicrobial Peptide eCATH1 Is Effective against the Facultative Intracellular Pathogen Rhodococcus equi in MiceAntimicrobial Agents and Chemotherapy, 2013
- Identification of a Novel Antimicrobial Peptide from Human Hepatitis B Virus Core Protein Arginine-Rich Domain (ARD)PLOS Pathogens, 2013
- The antimicrobial peptide cathelicidin modulates Clostridium difficile -associated colitis and toxin A-mediated enteritis in miceGut, 2012
- Strand Length-Dependent Antimicrobial Activity and Membrane-Active Mechanism of Arginine- and Valine-Rich β-Hairpin-Like Antimicrobial PeptidesAntimicrobial Agents and Chemotherapy, 2012
- The Insect Peptide Coprisin Prevents Clostridium difficile-Mediated Acute Inflammation and Mucosal Damage through Selective Antimicrobial ActivityAntimicrobial Agents and Chemotherapy, 2011
- Host Defense Peptide LL-37 Selectively Reduces Proinflammatory Macrophage ResponsesThe Journal of Immunology, 2011
- The proline-rich peptide Bac7(1-35) reduces mortality from Salmonella typhimurium in a mouse model of infectionBMC Microbiology, 2010
- Endotoxin, Capsule, and Bacterial Attachment Contribute to Neisseria meningitidis Resistance to the Human Antimicrobial Peptide LL-37Journal of Bacteriology, 2009
- Characterization for enterotoxin production, virulence factors, and antibiotic susceptibility of Staphylococcus aureus isolates from various foods in PortugalFood Microbiology, 2009
- Differential Bacterial Survival, Replication, and Apoptosis-Inducing Ability ofSalmonellaSerovars within Human and Murine MacrophagesInfection and Immunity, 2000